All In Biotech

Drug Trial Radar · NCT07454837

Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide

A Phase 2b/3, Open-Label, Multicenter Trial Evaluating the Efficacy and Safety of Switching to Brelovitug for the Treatment of Chronic Hepatitis Delta Infection in Participants Receiving Bulevirtide (AZURE-3)

Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

120

Planned (sponsor's estimate)

Start

Feb 26, 2026

Primary completion

Aug 31, 2027

Study completion Mar 30, 2029

Sponsor

Lead sponsor
Mirum Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Mar 6, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2b/3, randomized, open-label, multicenter trial evaluating the efficacy and safety of switching from bulevirtide to brelovitug for the treatment of chronic hepatitis Delta infection (CHD).

Conditions

  • Chronic Hepatitis D

Interventions

  • Brelovitug (BJT-778)Drug

    Brelovitug (BJT-778), 300 mg administered subcutaneously once weekly for 96 weeks.

  • BulevirtideDrug

    Bulevirtide - once daily. Brelovitug (BJT-778) - 300 mg once weekly for 72 weeks following bulevirtide.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants with undetectable HDV RNA (<LLOQ Target not detected [TND])Time frame: Week 24

Locations

46 sites in 8 countries. Site status is shown where the registry gives one.

  • Medical University of Graz

    Graz, Austria · Recruiting

  • Medizinische Universitat Innsbruck

    Innsbruck, Austria · Recruiting

  • University Hospital St. Polten- Lilenfeld

    Lilienfeld, Austria · Recruiting

  • Medical University of Vienna

    Vienna, Austria · Recruiting

  • Fakultni Nemocnice Brno (University Hospital Brno)

    Brno, Czechia · Recruiting

  • Klin Med Ltd. (KLIN MED s.r.o.)

    Prague, Czechia · Recruiting

  • Institut klinicke a experimentalni mediciny- IKEM (Institute for Clinical and Experimental Medicine)

    Prague, Czechia · Recruiting

  • CHU de Bordeaux

    Bordeaux, France · Recruiting

  • Clermont-Ferrand University Hospital

    Clermont-Ferrand, France · Recruiting

  • Hospital Beaujon

    Clichy, France · Recruiting

  • Centre Hospitalier Intercommunal De Creteil

    Créteil, France · Recruiting

  • Henri Mondor University Hospital (APHP)

    Créteil, France · Recruiting

  • CHU Grenoble Alpes Hopital Nord Michallon

    Grenoble, France · Recruiting

  • CHU de Lille

    Lille, France · Recruiting

  • CHU Limoges

    Limoges, France · Recruiting

  • Hospital De La Croix Rousse

    Lyon, France · Recruiting

  • Hopital Saint-Eloi

    Montpellier, France · Recruiting

  • Pitie-Salpetriere Hosptial

    Paris, France · Recruiting

  • Chu de Rennes Hopital Pontchaillou

    Rennes, France · Recruiting

  • CHU Toulouse Hospital Rangueil, Toulouse

    Toulouse, France · Recruiting

  • Centre Hospitalier de Versailles

    Versailles, France · Recruiting

  • University Hospital of Dusseldorf

    Düsseldorf, Germany · Recruiting

  • Goethe University Frankfurt

    Frankfurt, Germany · Recruiting

  • ICH Study Center GmbH & Co KG

    Hamburg, Germany · Recruiting

  • Medizinische Hochschule Hannover

    Hanover, Germany · Recruiting

  • Universitatsmedizin Rostock

    Rostock, Germany · Recruiting

  • Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII

    Bergamo, Italy · Recruiting

  • Humanitas Clinical and Research Center & Humanitas University

    Milan, Italy · Recruiting

  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

    Milan, Italy · Recruiting

  • ASST Grande Ospedale Metropolitano Niguarda

    Milan, Italy · Recruiting

  • National Institute Of Infectious Diseases Prof. Dr. Matei Bals

    Bucharest, Romania · Recruiting

  • Fundeni Clinical Institute

    Bucharest, Romania · Recruiting

  • Clinical Hospital for Infectious and Tropical Diseases Dr. Victor Babes

    Bucharest, Romania · Recruiting

  • National Institute Of Infectious Diseases Prof. Dr. Matei Bals

    Bucharest, Romania · Recruiting

  • Spitalul Clinic de Boli Infectioase Constanta

    Constanța, Romania · Recruiting

  • Centrul Medical Unirea S.R.L

    Iași, Lasi, Romania · Recruiting

  • Vall d'Hebron Hospital

    Barcelona, Spain · Recruiting

  • Hospital Clinic I Provincial De Barcelona

    Barcelona, Spain · Recruiting

  • Marques De Valdecilla University Hospital

    Cantoria, Spain · Recruiting

  • Hospital Universitario Ramon y Cajal

    Madrid, Spain · Recruiting

Showing 40 of 46 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.